- ISIN
- US16359R1032
- CUSIP
- 16359R103
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- May 3, 1973
Highlights
- Market Cap
- $5.96B
- Enterprise Value
- $6.22B
- EPS (TTM)
- $18.29
- PE Ratio
- 23.84
- PEG Ratio
- 11.23
- Total Revenue (TTM)
- $2.54B
- Gross Profit (TTM)
- $571.36M
- EBITDA (TTM)
- $396.47M
- Year Range
- $365.21 - $562.77
- Target Price
- $475.00
- ROA (TTM)
- 16.91%
- ROE (TTM)
- 30.64%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CHE Performance Chart
Chemed Corporation (CHE) is up 2.2% since the beginning of the year. At $436 per share, CHE is trading 22.5% below its 52-week high of $563. Investors who bought $1,000 worth of CHE shares 5 years ago would now be looking at an investment worth $923.
Loading charts...
Returns By Period
Chemed Corporation (CHE) has returned 2.19% so far this year and -20.09% over the past 12 months. Over the last ten years, CHE has returned 13.10% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Chemed Corporation
- 1D
- -0.05%
- 1M
- -0.61%
- YTD
- 2.19%
- 6M
- 0.34%
- 1Y
- -20.09%
- 3Y*
- -6.62%
- 5Y*
- -1.60%
- 10Y*
- 13.10%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CHE Monthly Returns History
Based on dividend-adjusted daily data since May 3, 1973, CHE's average daily return is +0.05%, while the average monthly return is +1.18%. At this rate, an investment would double in approximately 4.9 years.
Historically, 54% of months were positive and 46% were negative. The best month was Oct 1974 with a return of +66.7%, while the worst month was Sep 1974 at -53.9%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, CHE closed higher 44% of trading days. The best single day was Dec 19, 2003 with a return of +26.2%, while the worst single day was Sep 30, 1974 at -25.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.17% | -3.89% | -7.87% | 12.51% | 0.47% | 2.27% | 2.19% | ||||||
| 2025 | 6.08% | 7.00% | 2.42% | -5.49% | -1.06% | -15.29% | -15.33% | 11.23% | -2.23% | -3.67% | 1.97% | -2.58% | -18.87% |
| 2024 | 1.37% | 5.70% | 2.52% | -11.52% | -2.33% | -2.13% | 5.08% | 2.90% | 2.52% | -10.11% | 6.05% | -7.44% | -9.11% |
| 2023 | -1.04% | 3.33% | 3.10% | 2.51% | -3.10% | 1.48% | -3.80% | -1.78% | 1.62% | 8.26% | 0.84% | 3.13% | 14.90% |
| 2022 | -11.37% | 2.08% | 5.91% | -2.99% | -1.35% | -3.10% | 2.49% | -0.94% | -8.32% | 6.94% | 11.47% | -1.84% | -3.22% |
| 2021 | -2.76% | -13.97% | 3.28% | 3.65% | 3.16% | -3.43% | 0.32% | 0.22% | -2.43% | 3.68% | -3.41% | 13.65% | -0.38% |
Benchmark Metrics
Chemed Corporation has an annualized alpha of 8.08%, beta of 0.61, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since May 03, 1973.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.00%) than losses (79.40%) - typical of diversified or defensive assets.
- Beta of 0.61 may look defensive, but with R2 of 0.13 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 8.08%
- Beta
- 0.61
- R²
- 0.13
- Upside Capture
- 86.00%
- Downside Capture
- 79.40%
Return for Risk
Risk / Return Rank
CHE ranks 18 for risk / return — in the bottom 18% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Chemed Corporation (CHE) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CHE | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.64 | ||
| Sortino ratioReturn per unit of downside risk | -3.37 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.37 | -0.47 |
| Calmar ratioReturn relative to maximum drawdown | -0.60 | 2.78 | -3.38 |
| Martin ratioReturn relative to average drawdown | -0.90 | 12.44 | -13.34 |
Dividends
Dividend History
Chemed Corporation provided a 0.55% dividend yield over the last twelve months, with an annual payout of $2.40 per share. The company has been increasing its dividends for 25 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.40 | $2.20 | $1.80 | $1.56 | $1.48 | $1.40 | $1.32 | $1.24 | $1.16 | $1.08 | $1.00 | $0.92 |
Dividend yield | 0.55% | 0.51% | 0.34% | 0.27% | 0.29% | 0.26% | 0.25% | 0.28% | 0.41% | 0.44% | 0.62% | 0.61% |
Monthly Dividends
The table displays the monthly dividend distributions for Chemed Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $1.20 | ||||||
| 2025 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $2.20 |
| 2024 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $1.80 |
| 2023 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $1.56 |
| 2022 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $1.48 |
| 2021 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $1.40 |
Dividend Yield & Payout
Dividend Yield
Chemed Corporation has a dividend yield of 0.55%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Chemed Corporation has a payout ratio of 12.53%, which is below the market average. This means Chemed Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Chemed Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Chemed Corporation was 83.78%, occurring on Sep 30, 1974. Recovery took 1206 trading sessions.
The current Chemed Corporation drawdown is 32.33%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1974 bear market1974 | -83.78%Sep 1974 | 1y 4mo | 4y 9mo | 6y 2moMay 1973 - Jul 1979 |
Financial crisis2007–2009 | -54.28%Oct 2008 | 1y 3mo | 2y 6mo | 3y 9moJul 2007 - Apr 2011 |
1991 bear market1991 | -52.22%Jan 1991 | 3y 4mo | 2y 5mo | 5y 10moAug 1987 - Jun 1993 |
2006 bear market2006 | -50.93%Oct 2006 | 5mo 15d | 7mo 6d | 1y 16dApr 2006 - May 2007 |
2026 bear market2026 | -42.88%Mar 2026 | 2y 7d | — | 2y 3moMar 2024 - now |
Drawdown Indicators
| CHE | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.78% | -56.78% | -27.00% |
Max Drawdown (1Y)Largest decline over 1 year | -33.84% | -9.10% | -24.74% |
Max Drawdown (3Y)Largest decline over 3 years | -42.88% | -18.90% | -23.98% |
Max Drawdown (5Y)Largest decline over 5 years | -42.88% | -25.43% | -17.45% |
Max Drawdown (10Y)Largest decline over 10 years | -42.88% | -33.92% | -8.96% |
Current DrawdownCurrent decline from peak | -32.33% | -1.80% | -30.53% |
Average DrawdownAverage peak-to-trough decline | -16.46% | -10.71% | -5.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.35% | 2.03% | +20.32% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Chemed Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Chemed Corporation is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CHE, comparing it with other companies in the Medical Care Facilities industry. Currently, CHE has a P/E ratio of 23.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CHE compared to other companies in the Medical Care Facilities industry. CHE currently has a PEG ratio of 11.2. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CHE relative to other companies in the Medical Care Facilities industry. Currently, CHE has a P/S ratio of 2.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CHE in comparison with other companies in the Medical Care Facilities industry. Currently, CHE has a P/B value of 7.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CHE
Add Chemed Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CHE